# Study of the Safety of Intravenous Artesunate

> **NCT00292942** · PHASE1 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 26 (actual)

## Conditions studied

- Malaria
- Malaria, Cerebral

## Interventions

- **DRUG:** Intravenous Artesunate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00292942
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06-12
- **Primary completion:** 2007-01-17
- **Final completion:** 2008-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2018-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00292942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00292942, "Study of the Safety of Intravenous Artesunate". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00292942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*